W. Travis, C. Li, E. Bergstralh, L. Yam, and R. Swee, Systemic Mast Cell Disease, Medicine, vol.67, issue.6, pp.345-68, 1988.
DOI : 10.1097/00005792-198811000-00001

M. Arock and P. Valent, Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert review of hematology, pp.497-516

P. Valent, C. Akin, and L. Escribano, Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria, European Journal of Clinical Investigation, vol.95, issue.6
DOI : 10.1016/S0889-8588(05)70298-7
URL : https://hal.archives-ouvertes.fr/hal-00282493

C. Bodemer, O. Hermine, and F. Palmerini, Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations, Journal of Investigative Dermatology, vol.130, issue.3, pp.804-819
DOI : 10.1038/jid.2009.281
URL : https://hal.archives-ouvertes.fr/hal-00437282

E. Blackburn, Switching and Signaling at the Telomere, Cell, vol.106, issue.6, pp.661-73, 2001.
DOI : 10.1016/S0092-8674(01)00492-5

E. Blackburn, C. Greider, E. Henderson, M. Lee, J. Shampay et al., Recognition and elongation of telomeres by telomerase, Genome, vol.31, issue.2, pp.553-60, 1989.
DOI : 10.1139/g89-104

E. Blackburn and P. Challoner, Identification of a telomeric DNA sequence in Trypanosoma brucei, Cell, vol.36, issue.2, pp.447-57, 1984.
DOI : 10.1016/0092-8674(84)90238-1

L. Hayflick, The limited in vitro lifetime of human diploid cell strains, Experimental Cell Research, vol.37, issue.3, pp.614-650, 1965.
DOI : 10.1016/0014-4827(65)90211-9

R. Reddel, Alternative lengthening of telomeres, telomerase, and cancer, Cancer Letters, vol.194, issue.2, pp.155-62, 2003.
DOI : 10.1016/S0304-3835(02)00702-4

C. Chaves-dias, T. Hundley, and A. Gilfillan, Induction of Telomerase Activity During Development of Human Mast Cells from Peripheral Blood CD34+ Cells: Comparisons with Tumor Mast-Cell Lines, The Journal of Immunology, vol.166, issue.11, pp.6647-56, 2001.
DOI : 10.4049/jimmunol.166.11.6647

U. Tabori and J. Dome, Telomere Biology of Pediatric Cancer, Cancer Investigation, vol.60, issue.19, pp.197-208, 2007.
DOI : 10.1038/sj.onc.1204954

Y. Yang, S. Letard, and L. Borge, Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations, Blood, vol.116, issue.7, pp.1114-1137
DOI : 10.1182/blood-2009-06-226027

C. Harley, A. Futcher, and C. Greider, Telomeres shorten during ageing of human fibroblasts, Nature, vol.345, issue.6274, pp.458-60, 1990.
DOI : 10.1038/345458a0

C. Harley, H. Vaziri, C. Counter, and R. Allsopp, The telomere hypothesis of cellular aging, Experimental Gerontology, vol.27, issue.4, pp.375-82, 1992.
DOI : 10.1016/0531-5565(92)90068-B

E. Epel, E. Blackburn, J. Lin, F. Dhabhar, N. Adler et al., Accelerated telomere shortening in response to life stress, Proceedings of the National Academy of Sciences, vol.101, issue.49, pp.17312-17317, 2004.
DOI : 10.1073/pnas.0407162101

H. Kao, . Cr, L. Delisi, H. Bertisch, J. F. Gordon et al., Rapid telomere erosion in schizophrenia, Molecular Psychiatry, vol.13, issue.2, pp.118-127, 2008.
DOI : 10.1001/archpsyc.58.4.361

O. Donovan, A. Lin, J. Dhabhar, F. Wolkowitz, O. Tillie et al., Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women, Brain, Behavior, and Immunity, vol.23, issue.4, pp.446-455, 2009.
DOI : 10.1016/j.bbi.2008.11.006

O. Wolkowitz, E. Epel, V. Reus, and S. Mellon, Depression gets old fast: do stress and depression accelerate cell aging?, Depression and Anxiety, vol.256, issue.3, pp.327-365, 2010.
DOI : 10.1002/da.20686

K. Lennert and M. Parwaresch, Mast cells and mast cell neoplasia: a review, Histopathology, vol.70, issue.5, pp.349-65, 1979.
DOI : 10.1007/BF01486688

D. Metcalfe, Classification and Diagnosis of Mastocytosis: Current Status, Journal of Investigative Dermatology, vol.96, issue.3, pp.2-4, 1991.
DOI : 10.1111/1523-1747.ep12468882

P. Valent, H. Horny, L. Escribano, B. Longley, C. Li et al., Diagnostic criteria and classification of mastocytosis: a consensus proposal, Leukemia Research, vol.25, issue.7, pp.603-628, 2001.
DOI : 10.1016/S0145-2126(01)00038-8

. Mastocytosis, C. Akin, W. Sperr, H. Horny, and D. Metcalfe, World Health Organization (WHO) Classification of tumours Mast cell proliferative disorders: current view on variants recognized by the World Health Organization, Hematol Oncol Clin North Am, vol.17, pp.1227-1268, 2001.

K. Lim, A. Tefferi, T. Lasho, C. Finke, M. Patnaik et al., Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors, Blood, vol.113, issue.23, pp.5727-5763, 2009.
DOI : 10.1182/blood-2009-02-205237

O. Hermine, O. Lortholary, P. Leventhal, A. Catteau, F. Soppelsa et al., Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis, PLoS ONE, vol.14, issue.5, pp.2266-15437, 1986.
DOI : 10.1371/journal.pone.0002266.s002
URL : https://hal.archives-ouvertes.fr/hal-00284181

G. Addolorato, L. Marsigli, E. Capristo, F. Caputo, C. Dall-'aglio et al., Anxiety and depression: a common feature of health care seeking patients with irritable bowel syndrome and food allergy, Hepatogastroenterology, vol.45, pp.1559-64, 1998.

P. Lehrer, S. Isenberg, and S. Hochron, Asthma and Emotion: A Review, Journal of Asthma, vol.60, issue.1, pp.5-21, 1993.
DOI : 10.1001/archpsyc.1984.01790190038004

K. Nautiyal, A. Ribeiro, D. Pfaff, and R. Silver, Brain mast cells link the immune system to anxiety-like behavior, Proceedings of the National Academy of Sciences, vol.105, issue.46, pp.18053-18060, 2008.
DOI : 10.1073/pnas.0809479105

F. Costa-pinto, A. Basso, and M. Russo, Role of mast cell degranulation in the neural correlates of the immediate allergic reaction in a murine model of asthma, Brain, Behavior, and Immunity, vol.21, issue.6, pp.783-90, 2007.
DOI : 10.1016/j.bbi.2007.01.002

H. Walter, V. Kalckreuth, A. Schardt, D. Stephan, A. Goschke et al., The Temporal Dynamics of Voluntary Emotion Regulation, PLoS ONE, vol.10, issue.8, p.6726, 2009.
DOI : 10.1371/journal.pone.0006726.t002

J. Bienenstock, M. Tomioka, H. Matsuda, R. Stead, G. Quinonez et al., The Role of Mast Cells in Inflammatory Processes: Evidence for Nerve/Mast Cell Interactions, International Archives of Allergy and Immunology, vol.82, issue.3-4, pp.238-281, 1987.
DOI : 10.1159/000234197

T. Theoharides, Autism Spectrum Disorders and Mastocytosis, International Journal of Immunopathology and Pharmacology, vol.29, issue.1, pp.859-65, 2009.
DOI : 10.1016/S0145-2126(01)00038-8

T. Theoharides, Mast cells: The immune gate to the brain, Life Sciences, vol.46, issue.9, pp.607-624, 1990.
DOI : 10.1016/0024-3205(90)90129-F

T. Theoharides, C. Spanos, X. Pang, L. Alferes, K. Ligris et al., Stressinduced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect, Endocrinology, vol.136, pp.5745-50, 1995.

C. Bodemer, O. Hermine, F. Palmerini, Y. Yang, C. Grandpeix-guyodo et al., Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations, Journal of Investigative Dermatology, vol.130, issue.3, pp.804-819
DOI : 10.1038/jid.2009.281
URL : https://hal.archives-ouvertes.fr/hal-00437282

K. Hahn, G. Ogilvie, T. Rusk, P. Devauchelle, A. Leblanc et al., Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors, Journal of Veterinary Internal Medicine, vol.22, issue.6, pp.1301-1310, 2008.
DOI : 10.1111/j.1939-1676.2008.0190.x

L. Schwartz, T. Bradford, C. Rouse, A. Irani, G. Rasp et al., Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis, Journal of Clinical Immunology, vol.86, issue.Suppl C, pp.190-204, 1994.
DOI : 10.1007/BF01533368

W. Sperr, J. Jordan, M. Baghestanian, H. Kiener, P. Samorapoompichit et al., Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia, Blood, vol.98, issue.7, pp.2200-2209, 2001.
DOI : 10.1182/blood.V98.7.2200

T. Aaron, R. Beck, G. K. Brown-spielberger, C. Gorsush, R. L. Lushene et al., Beck Depression Inventory?Second Edition (BDI-II) San Antonio, TX: The Psychological Corporation 1996, Manual for the State-Trait Anxiety Inventory (Form Y), 1983.

S. Cohen, T. Kamarch, and R. Mermelstein, A Global Measure of Perceived Stress, Journal of Health and Social Behavior, vol.24, issue.4, pp.385-96, 1983.
DOI : 10.2307/2136404

R. Lazarus, S. Folkman, and . Stress, Coping and Adaptation 33. Gross JJ. Emotion regulation: affective, cognitive, and social consequences, Psychophysiology, vol.39, pp.281-91, 1984.

R. Bagby, G. Taylor, and J. Parker, The Twenty-item Toronto Alexithymia Scale--II

. Convergent, J. Gross, and O. John, Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being The moderator-mediator variable distinction in social psychological research: Conceptual, strategic and statistical considerations, J Psychosom Res J Pers Soc Psychol Baron RM Journal of Personality and Social Psychology, vol.38, issue.51, pp.33-40348, 1986.

Y. Okayama, Oxidative Stress in Allergic and Inflammatory Skin Diseases, Current Drug Target -Inflammation & Allergy, vol.4, issue.4, pp.517-526, 2005.
DOI : 10.2174/1568010054526386

K. Wolfreys and D. Oliveira, Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function, European Journal of Immunology, vol.10, issue.1, pp.297-306, 1997.
DOI : 10.1002/eji.1830270143

R. Wright, R. Cohen, and S. Cohen, The impact of stress on the development and expression of atopy, Current Opinion in Allergy and Clinical Immunology, vol.5, issue.1, pp.23-32, 2005.
DOI : 10.1097/00130832-200502000-00006

E. Epel, Psychological and metabolic stress: A recipe for accelerated cellular aging?, HORMONES, vol.8, issue.1, pp.7-22, 2009.
DOI : 10.14310/horm.2002.1217

B. 1. Fain, O. Stirnemann, J. Eclache, and V. , Systemic Mastocytosis, Allergy and Asthma Proceedings, vol.3, issue.1, pp.681-688, 2005.
DOI : 10.2500/108854182779089544

S. Georgin-lavialle, S. Barete, and F. Suarez, Actualit??s sur la compr??hension et le traitement des mastocytoses syst??miques, La Revue de M??decine Interne, vol.30, issue.1, pp.25-34, 2009.
DOI : 10.1016/j.revmed.2008.01.025

W. Travis, C. Li, E. Bergstralh, L. Yam, and R. Swee, Systemic Mast Cell Disease, Medicine, vol.67, issue.6, pp.345-68, 1988.
DOI : 10.1097/00005792-198811000-00001

K. Lennert and M. Parwaresch, Mast cells and mast cell neoplasia: a review, Histopathology, vol.70, issue.5, pp.349-65, 1979.
DOI : 10.1007/BF01486688

M. Parwaresch, H. Horny, and K. Lennert, Tissue mast cells in health and disease, Pathology - Research and Practice, vol.179, issue.4-5, pp.439-61, 1985.
DOI : 10.1016/S0344-0338(85)80184-9

H. Agis, M. Willheim, and W. Sperr, Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell, J Immunol, vol.151, pp.4221-4228, 1993.

A. Kirshenbaum, J. Goff, T. Semere, B. Foster, L. Scott et al., Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13), Blood, vol.94, pp.2333-2375, 1999.

M. Rottem, T. Okada, J. Goff, and D. Metcalfe, Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI-cell population, Blood, vol.84, pp.2489-96, 1994.

P. Valent, D. Bevec, and D. Maurer, Interleukin 4 promotes expression of mast cell ICAM-1 antigen., Proceedings of the National Academy of Sciences, vol.88, issue.8
DOI : 10.1073/pnas.88.8.3339

V. Payne and P. Kam, Mast cell tryptase: a review of its physiology and clinical significance, Anaesthesia, vol.75, issue.7, pp.695-703, 2004.
DOI : 10.1046/j.1399-6576.2003.00237.x

H. Mitsui, T. Furitsu, and A. Dvorak, Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand Valent P, Bettelheim P. Cell surface structures on human basophils and mast cells: biochemical and functional characterization Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis, Proc Natl Acad Sci U S A Advances in immunology Blood, vol.905284, issue.14, pp.735-9333, 1992.

P. Valent, E. Spanblochl, and W. Sperr, Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kitligand in long-term culture, Blood, vol.80, pp.2237-2282, 1992.

I. Mcniece and R. Briddell, Stem cell factor, Journal of leukocyte biology, vol.58, pp.14-22, 1995.

P. Valent, Cytokines involved in growth and differentiation of human basophils and mast cells, Experimental Dermatology, vol.84, issue.4, pp.255-264, 1995.
DOI : 10.1084/jem.175.1.237

D. Linnekin, Early signaling pathways activated by c-Kit in hematopoietic cells, The International Journal of Biochemistry & Cell Biology, vol.31, issue.10, pp.1053-74, 1999.
DOI : 10.1016/S1357-2725(99)00078-3

L. Schwartz, Mast cells and basophils, Clinical allergy and immunology, vol.16, pp.3-42, 2002.

O. Lortholary, J. Audouin, L. Tourneau, A. Diebold, and J. , The mast cell and its pathology. 2: Histopathology of mastocytosis], Annales de pathologie, vol.11, pp.92-100, 1991.

F. Marrache, N. Memain, and I. Bonte, Traitement des mastocytoses syst??miques, La Revue de M??decine Interne, vol.24, issue.9, pp.594-601, 2003.
DOI : 10.1016/S0248-8663(03)00141-3

J. Fine and . Mastocytosis, Mastocytosis, International Journal of Dermatology, vol.38, issue.11, pp.117-140, 1980.
DOI : 10.1001/archderm.113.9.1245

A. Chang, R. Tung, T. Schlesinger, W. Bergfeld, J. Dijkstra et al., Familial Cutaneous Mastocytosis, Pediatric Dermatology, vol.96, issue.4, pp.271-277, 2001.
DOI : 10.1056/NEJM199305063281803

K. Lim, A. Tefferi, and T. Lasho, Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies, Blood Blood, vol.113114, pp.5727-363769, 2009.

O. Hermine, O. Lortholary, and P. Leventhal, Case-control cohort study of patients' perceptions of disability in mastocytosis Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product Role of c-kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cells Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy, PLoS ONE J Clin Invest Pathol Int Leuk Res, vol.3924625, pp.2266-281736, 1993.

C. Akin and D. Metcalfe, Systemic Mastocytosis, Annual Review of Medicine, vol.55, issue.1, pp.419-451, 2004.
DOI : 10.1146/annurev.med.55.091902.103822
URL : https://hal.archives-ouvertes.fr/hal-00282550

C. Akin and D. Metcalfe, The biology of Kit in disease and the application of pharmacogenetics

F. Feger, R. Dumas, A. Leriche, L. Valent, P. Arock et al., Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients, Tefferi A, Pardanani A. Clinical, genetic, and therapeutic insights into systemic mast cell disease, pp.13-9110, 1995.

C. Akin, G. Fumo, A. Yavuz, P. Lipsky, L. Neckers et al., A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant, Blood Mol Cancer Ther, vol.1031, issue.39, pp.3222-51115, 2002.

Y. Zhang, B. Schlegelberger, K. Weber-matthiesen, W. Grote, H. Bartels et al., Translocation (X;8)(q2?6;q21.3) in a case of systemic mastocytosis Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations, Cancer genetics and cytogenetics The Journal of investigative dermatology, vol.78130, pp.236-8804, 1994.

C. Larroche, M. Chadenat, M. Chaunu, S. Abad, P. Casassus et al., Accident vasculaire c??r??bral sur dissection art??rielle, au cours des mastocytoses syst??miques??: une association non fortuite??? ?? propos de deux cas, La Revue de M??decine Interne, vol.26, issue.10, pp.820-823, 2005.
DOI : 10.1016/j.revmed.2005.06.004

R. Maldonado, Cutaneous mastocytosis in children: a clinical analysis of 71 cases, J Eur Acad Dermatol Venereol, vol.18, pp.285-90, 2004.

O. Fain, J. Stirnemann, and O. Lortholary, Systemic Mastocytosis, Allergy and Asthma Proceedings, vol.3, issue.1, pp.1629-1665, 2005.
DOI : 10.2500/108854182779089544

P. Valent, W. Sperr, and C. Akin, How I treat patients with advanced systemic mastocytosis. Blood, pp.5812-5819

E. Blackburn, Switching and Signaling at the Telomere, Cell, vol.106, issue.6, pp.661-73, 2001.
DOI : 10.1016/S0092-8674(01)00492-5

E. Blackburn and P. Challoner, Identification of a telomeric DNA sequence in Trypanosoma brucei, Cell, vol.36, issue.2, pp.447-57, 1984.
DOI : 10.1016/0092-8674(84)90238-1

W. Hahn, Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer, Journal of Clinical Oncology, vol.21, issue.10, pp.2034-2077, 2003.
DOI : 10.1200/JCO.2003.06.018

H. Vaziri, F. Schachter, and I. Uchida, Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes, Am J Hum Genet, vol.52, pp.661-668, 1993.

S. Poon, U. Martens, R. Ward, and P. Lansdorp, Telomere length measurements using digital fluorescence microscopy, Cytometry, vol.32, issue.4, pp.267-78, 1999.
DOI : 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O

N. Rufer, W. Dragowska, G. Thornbury, E. Roosnek, and P. Lansdorp, Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry, Cech TR. Beginning to understand the end of the chromosome, pp.743-7273, 1998.
DOI : 10.1073/pnas.94.14.7423

M. Djojosubroto, Y. Choi, H. Lee, and K. Rudolph, Telomeres and telomerase in aging, regeneration and cancer, Mol Cells, vol.15, pp.164-75, 2003.

G. Yu, E. Blackburn, T. Lendvay, D. Morris, J. Sah et al., Developmentally programmed healing of chromosomes by telomerase in Tetrahymena Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes, Cell Genetics, vol.67144, issue.57, pp.823-321399, 1991.

J. Lingner and T. Cech, Purification of telomerase from Euplotes aediculatus: requirement of a primer 3' overhang., Proceedings of the National Academy of Sciences, vol.93, issue.20, pp.10712-10719, 1996.
DOI : 10.1073/pnas.93.20.10712

J. Lingner, T. Hughes, A. Shevchenko, M. Mann, V. Lundblad et al., Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase, Science, vol.276, issue.5312, pp.561-568, 1997.
DOI : 10.1126/science.276.5312.561

N. Kim, M. Piatyszek, and K. Prowse, Specific association of human telomerase activity with immortal cells and cancer, Science, vol.266, issue.5193, pp.2011-2016, 1994.
DOI : 10.1126/science.7605428

Y. Wu, A. Hruszkewycz, and R. Delgado, Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays, Clinica Chimica Acta, vol.293, issue.1-2, pp.199-212, 2000.
DOI : 10.1016/S0009-8981(99)00238-7

M. Hou, D. Xu, M. Bjorkholm, A. Gruber, C. Chaves-dias et al., Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity Induction of telomerase activity during development of human mast cells from peripheral blood CD34+ cells: comparisons with tumor mastcell lines Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines, Clinical chemistry J Immunol Nature medicine, vol.471663, issue.65, pp.519-246647, 1997.

T. Bryan, A. Englezou, J. Gupta, S. Bacchetti, and R. Reddel, Telomere elongation in immortal human cells without detectable telomerase activity, The EMBO journal, vol.14, pp.4240-4248, 1995.

M. Dunham, A. Neumann, C. Fasching, and R. Reddel, Telomere maintenance by recombination in human cells, Nature genetics, vol.26, pp.447-50, 2000.

R. Reddel, Alternative lengthening of telomeres, telomerase, and cancer, Cancer Letters, vol.194, issue.2, pp.155-62, 2003.
DOI : 10.1016/S0304-3835(02)00702-4

J. Campisi, S. Kim, C. Lim, and M. Rubio, Cellular senescence, cancer and aging: the telomere connection, Experimental Gerontology, vol.36, issue.10, pp.1619-1656, 2001.
DOI : 10.1016/S0531-5565(01)00160-7

G. Dimri, X. Lee, and G. Basile, A biomarker that identifies senescent human cells in culture and in aging skin in vivo., Proceedings of the National Academy of Sciences, vol.92, issue.20, pp.9363-9370, 1995.
DOI : 10.1073/pnas.92.20.9363

L. Hayflick, The limited in vitro lifetime of human diploid cell strains, Experimental Cell Research, vol.37, issue.3, pp.614-650, 1965.
DOI : 10.1016/0014-4827(65)90211-9

V. Gire and D. Wynford-thomas, Reinitiation of DNA Synthesis and Cell Division in Senescent Human Fibroblasts by Microinjection of Anti-p53 Antibodies, Molecular and Cellular Biology, vol.18, issue.3, pp.1611-1632, 1998.
DOI : 10.1128/MCB.18.3.1611

M. Hande, E. Samper, P. Lansdorp, M. Blasco, K. Nakabayashi et al., Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice DNA topoisomerase inhibitors induce reversible senescence in normal human fibroblasts Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts, The Journal of cell biology Oncogene, vol.14425316, issue.75, pp.589-601667, 1998.

M. Akiyama, O. Yamada, and N. Kanda, Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors, Cancer Letters, vol.178, issue.2, pp.187-97, 2002.
DOI : 10.1016/S0304-3835(01)00838-2

X. Gao and Y. Chen, Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-??-induced apoptosis in prostate cancer cells, Asian Journal of Andrology, vol.9, issue.5, pp.697-704, 2007.
DOI : 10.1111/j.1745-7262.2007.00297.x

S. Li, M. Ferguson, C. Hawkins, C. Smith, N. Elwood et al., Human telomerase reverse transcriptase protects hematopoietic progenitor TF-1 cells from death and quiescence induced by cytokine withdrawal Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells, Leukemia International journal of oncology, vol.2021, issue.79, pp.1270-81087, 2002.

P. Wu, L. Meng, and H. Wang, Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. Biochemical and biophysical research communications New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin, Oncogene, vol.33521, issue.81, pp.36-44553, 2002.

K. Masutomi, R. Possemato, and J. Wong, The telomerase reverse transcriptase regulates chromatin state and DNA damage responses Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity, Proc Natl Acad Sci U S A Clin Cancer Res, vol.10210, issue.83, pp.8222-72551, 2004.

A. Bodnar, M. Ouellette, and M. Frolkis, Extension of Life-Span by Introduction of Telomerase into Normal Human Cells, Science, vol.279, issue.5349, pp.349-52, 1998.
DOI : 10.1126/science.279.5349.349

H. Vaziri and S. Benchimol, Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span, Current Biology, vol.8, issue.5, pp.279-82, 1998.
DOI : 10.1016/S0960-9822(98)70109-5

M. Engelhardt, P. Drullinsky, J. Guillem, M. Moore, K. Kolquist et al., Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer Expression of TERT in early premalignant lesions and a subset of cells in normal tissues, Clin Cancer Res Nature genetics, vol.319, issue.87, pp.1931-41182, 1997.

P. Yan, J. Coindre, J. Benhattar, F. Bosman, and L. Guillou, Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity, Cancer research, vol.59, pp.3166-70, 1999.

D. Gisselsson, T. Jonson, and A. Petersen, Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors Telomere dysfunction and evolution of intestinal carcinoma in mice and humans Longevity, stress response, and cancer in aging telomerase-deficient mice, Proc Natl Acad Sci U S A Nature genetics Cell, vol.982896, issue.91, pp.12683-8155, 1999.

E. Epel, . Psychological, J. Lin, and F. Dhabhar, Dynamics of telomerase activity in response to acute psychological stress The power of exercise: buffering the effect of chronic stress on telomere length A review of 17 IV-S neuroblastoma patients at the children's hospital of philadelphia Spontaneous regression of low-grade astrocytomas in childhood, Hormones (Athens, Greece) Brain Behav Immun PLoS One Cancer Schmandt SM Pediatric neurosurgery, vol.82454532, issue.95, pp.7-22531, 1980.

B. Mccormack, D. Miller, G. Budzilovich, G. Voorhees, and J. Ransohoff, Treatment and Survival of Low-Grade Astrocytoma in Adults--1977???1988, Neurosurgery, vol.31, issue.4, pp.636-678, 1992.
DOI : 10.1227/00006123-199210000-00004

K. Watanabe, K. Sato, and W. Biernat, Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies, Clin Cancer Res, vol.3, pp.523-553, 1997.

A. Zipursky, Transient leukaemia - a benign form of leukaemia in newborn infants with trisomy 21, British Journal of Haematology, vol.81, issue.6, pp.930-938, 2003.
DOI : 10.1097/00043426-199602000-00003

S. Holt, E. Brown, and A. Zipursky, Telomerase and the Benign and Malignant Megakaryoblastic Leukemias of Down Syndrome, Journal of Pediatric Hematology/Oncology, vol.24, issue.1, pp.14-21, 2002.
DOI : 10.1097/00043426-200201000-00005

U. Tabori, B. Vukovic, and M. Zielenska, The Role of Telomere Maintenance in the Spontaneous Growth Arrest of Pediatric Low-Grade Gliomas, Neoplasia, vol.8, issue.2, pp.136-178, 2006.
DOI : 10.1593/neo.05715

U. Tabori, J. Ma, and M. Carter, Human Telomere Reverse Transcriptase Expression Predicts Progression and Survival in Pediatric Intracranial Ependymoma, Journal of Clinical Oncology, vol.24, issue.10, pp.1522-1530, 2006.
DOI : 10.1200/JCO.2005.04.2127

D. Didiano, T. Shalaby, D. Lang, and M. Grotzer, Telomere maintenance in childhood primitive neuroectodermal brain tumors, Neuro-Oncology, vol.6, issue.1, pp.1-8, 2004.
DOI : 10.1215/S1152851703000176

N. Binz, T. Shalaby, P. Rivera, K. Shin-ya, and M. Grotzer, Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells, European Journal of Cancer, vol.41, issue.18, pp.2873-81, 2005.
DOI : 10.1016/j.ejca.2005.08.025

D. Slater, The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants, British Journal of Dermatology, vol.19, issue.5, pp.874-80, 2005.
DOI : 10.1002/ajh.20019

N. Bories, L. Thomas, and A. Phan, Papulose lymphomato??de de l???enfant??: six cas et revue de la litt??rature, Annales de Dermatologie et de V??n??r??ologie, vol.135, issue.10, pp.657-62, 2008.
DOI : 10.1016/j.annder.2008.07.054

A. De-souza, M. Camilleri, D. Wada, D. Appert, L. Gibson et al., Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients, Journal of the American Academy of Dermatology, vol.61, issue.6, pp.993-1000, 2009.
DOI : 10.1016/j.jaad.2009.05.014

Y. Zermati, D. Sepulveda, P. Feger, and F. , Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms, Oncogene, vol.22, issue.5, pp.660-664, 2003.
DOI : 10.1038/sj.onc.1206120
URL : https://hal.archives-ouvertes.fr/hal-00282566

M. Gabillot-carre, Y. Lepelletier, and M. Humbert, Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells, Blood, vol.108, issue.3, pp.1065-72, 2006.
DOI : 10.1182/blood-2005-06-2433
URL : https://hal.archives-ouvertes.fr/hal-00282505

R. Baron and D. Kenny, The moderator???mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations., Journal of Personality and Social Psychology, vol.51, issue.6, pp.51-1173, 1986.
DOI : 10.1037/0022-3514.51.6.1173

Y. Okayama, Oxidative Stress in Allergic and Inflammatory Skin Diseases, Current Drug Target -Inflammation & Allergy, vol.4, issue.4, pp.517-526, 2005.
DOI : 10.2174/1568010054526386

O. Donovan, A. Lin, J. Dhabhar, and F. , Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women, Brain, Behavior, and Immunity, vol.23, issue.4, pp.446-455, 2009.
DOI : 10.1016/j.bbi.2008.11.006

K. Lindstedt, M. Mayranpaa, and P. Kovanen, Mast cells in vulnerable atherosclerotic plaques ??? a view to a kill, Journal of Cellular and Molecular Medicine, vol.87, issue.4, pp.739-58, 2007.
DOI : 10.1159/000083842

H. Butt, G. Atturu, N. London, R. Sayers, and M. Bown, Telomere Length Dynamics in Vascular Disease: A Review, European Journal of Vascular and Endovascular Surgery, vol.40, issue.1, pp.17-26
DOI : 10.1016/j.ejvs.2010.04.012

E. Demerath, N. Cameron, M. Gillman, B. Towne, and R. Siervogel, Telomeres and telomerase in the fetal origins of cardiovascular disease: a review Human biology; an international record of research, pp.127-173, 2004.

M. Satoh, Y. Ishikawa, Y. Takahashi, T. Itoh, Y. Minami et al., Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease, Atherosclerosis, vol.198, issue.2, pp.347-53, 2008.
DOI : 10.1016/j.atherosclerosis.2007.09.040

P. Van-der-harst, R. De-boer, and N. Samani, Telomere length and outcome in heart failure, Annals of Medicine, vol.102, issue.1, pp.36-44
DOI : 10.1093/eurheartj/ehm177

C. Bodemer, O. Hermine, F. Palmérini, C. Grandpeix-guyodo, P. Leventhal et al., Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations, Journal of Investigative Dermatology, vol.130, issue.3, pp.804-819, 2010.
DOI : 10.1038/jid.2009.281
URL : https://hal.archives-ouvertes.fr/hal-00437282

H. Sokol, S. Georgin-lavialle, C. Grandpeix-guyodo, D. Canioni, S. Barete et al., Gastrointestinal involvment and manifestations in systemic mastocytosis. Inflam Bowel Dis, pp.1247-53, 2010.

S. Georgin-lavialle, A. Aouba, L. Mouthon, Y. Lepelletier, A. Gabet et al., The telomere/telomerase system in autoimmune and systemix diseases Blood CD34 -C-KIT + cells rate correlates to aggressive forms of systemic mastocytosis and constitute a mast cell precursor, En revision à Blood, 2010.

S. Georgin-lavialle, F. Suarez, Y. Lepelletier, Y. Yang, S. Letard et al., Mast cell leukemia, Blood, vol.121, issue.8
DOI : 10.1182/blood-2012-07-442400
URL : https://hal.archives-ouvertes.fr/hal-00844934

M. Launay, F. Subra, L. Lhermitte, V. Asnafi, C. Auclair et al., KIT mutant inhibition: relevance in diagnostic and prognostic of systemic mastocytosis

S. Georgin-lavialle, D. S. Moura, A. Gabet, A. Gacon, C. Grandpeix-guyodo et al., Telomere shortening in mastocytosis is associated with depression, stress, anxiety and emotion regulation deficits, En révision au Journal of Allergy and Clinical Immunology

*. Georgin-lavialle-sophie, Baude Cédric 3* , Barete Stéphane 2,4 , Lhermitte Ludovic 5, Jean-Marie Launay, vol.1, issue.10

. Département-de-dermatologie-allergologie, et centre de référence sur les mastocytoses, Hôpital Tenon

R. 1. Horny, H. Parwaresch, M. Lennert, and K. , Bone marrow findings in systemic mastocytosis, Human Pathology, vol.16, issue.8, pp.808-814, 1985.
DOI : 10.1016/S0046-8177(85)80252-5

K. Lennert and M. Parwaresch, Mast cells and mast cell neoplasia: a review, Histopathology, vol.70, issue.5, pp.349-365, 1979.
DOI : 10.1007/BF01486688

D. Metcalfe, Classification and Diagnosis of Mastocytosis: Current Status, Journal of Investigative Dermatology, vol.96, issue.3, pp.2-4, 1991.
DOI : 10.1111/1523-1747.ep12468882

P. Valent and . Biology, classification and treatment of human mastocytosis, Wien Klin Wochenschr, vol.108, pp.385-397, 1996.

P. Valent, H. Horny, and L. Escribano, Diagnostic criteria and classification of mastocytosis: a consensus proposal, Leukemia Research, vol.25, issue.7, pp.603-625, 2001.
DOI : 10.1016/S0145-2126(01)00038-8

P. Valent, . Hh-p, L. Escribano, B. Longley, C. Li et al., World Health Organization (WHO) Classification of tumours, 2001.

P. Valent, C. Akin, W. Sperr, H. Horny, and D. Metcalfe, Mast cell proliferative disorders: current view on variants recognized by the World Health Organization, Hematology/Oncology Clinics of North America, vol.17, issue.5, pp.1227-1241, 2003.
DOI : 10.1016/S0889-8588(03)00089-3

P. Valent, G. Schernthaner, and W. Sperr, Variable expression of activation-linked surface antigens on human mast cells in health and disease, Immunological Reviews, vol.179, issue.1, pp.74-81, 2001.
DOI : 10.1034/j.1600-065X.2001.790108.x

L. Escribano, B. Diaz-agustin, and C. Bellas, Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis, Leukemia Research, vol.25, issue.7, pp.563-570, 2001.
DOI : 10.1016/S0145-2126(01)00050-9

L. Escribano, B. Diaz-agustin, and A. Lopez, Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it, Proposals of the Spanish Network on Mastocytosis (REMA)

L. Escribano, B. Diaz-agustin, R. Nunez, A. Prados, R. Rodriguez et al., Abnormal Expression of CD Antigens in Mastocytosis, International Archives of Allergy and Immunology, vol.127, issue.2, pp.127-132, 2002.
DOI : 10.1159/000048183

L. Escribano, A. Orfao, and B. Diaz-agustin, Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications, Blood, vol.91, pp.2731-2736, 1998.

L. Escribano, A. Orfao, and J. Villarrubia, Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia, Cytometry, vol.30, issue.2, pp.98-102, 1997.
DOI : 10.1002/(SICI)1097-0320(19970415)30:2<98::AID-CYTO4>3.0.CO;2-9

C. Teodosio, A. Garcia-montero, and M. Jara-acevedo, Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes Demonstration that human mast cells arise from a progenitor cell population that is CD34, and expresses aminopeptidase N (CD13), pp.719-726, 1999.

M. Arock, L. Nours, A. Malbec, O. Daeron, and M. , Ex Vivo and In Vitro Primary Mast Cells, Methods Mol Biol, vol.415, pp.241-254, 2008.
DOI : 10.1007/978-1-59745-570-1_14
URL : https://hal.archives-ouvertes.fr/pasteur-00269312

B. Lebel, A high-sampling-rate automated continuous-flow fluorometric technique for the analysis of nanogram levels of histamine in biological samples, Analytical Biochemistry, vol.133, issue.1, pp.16-29, 1983.
DOI : 10.1016/0003-2697(83)90217-8

C. Bodemer, O. Hermine, and F. Palmerini, Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations, Journal of Investigative Dermatology, vol.130, issue.3, pp.804-815
DOI : 10.1038/jid.2009.281
URL : https://hal.archives-ouvertes.fr/hal-00437282

K. Hahn, G. Ogilvie, and T. Rusk, Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors, Journal of Veterinary Internal Medicine, vol.22, issue.6, pp.1301-1309, 2008.
DOI : 10.1111/j.1939-1676.2008.0190.x

L. Schwartz, T. Bradford, and C. Rouse, Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis, Journal of Clinical Immunology, vol.86, issue.Suppl C, pp.190-204, 1994.
DOI : 10.1007/BF01533368

W. Sperr, J. Jordan, and M. Baghestanian, Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia, Blood, vol.98, issue.7, pp.2200-2209, 2001.
DOI : 10.1182/blood.V98.7.2200

K. Lim, A. Tefferi, and T. Lasho, Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors, Blood, vol.113, issue.23, pp.5727-5736, 2009.
DOI : 10.1182/blood-2009-02-205237

A. Pardanani, K. Lim, and T. Lasho, Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies, Blood, vol.114, issue.18, 2009.
DOI : 10.1182/blood-2009-05-220145

. Grandpeix-guyodo, Danielle Canioni 5,6 , Vahid Asnafi 4

. Pr, C. Olivier-hermine, and . Umr, 161 rue de Sèvres, 75743 Paris Cedex 15, France; Tel: +33 144 495 386; Fax: +33 144 495 280; e-mail: ohermine@gmail.com or Patrice Dubreuil

R. 1. Horny, H. Parwaresch, M. Lennert, and K. , Bone marrow findings in systemic mastocytosis, Human Pathology, vol.16, issue.8, pp.808-814, 1985.
DOI : 10.1016/S0046-8177(85)80252-5

K. Lennert and M. Parwaresch, Mast cells and mast cell neoplasia: a review, Histopathology, vol.70, issue.5, pp.349-365, 1979.
DOI : 10.1007/BF01486688

D. Metcalfe, Classification and Diagnosis of Mastocytosis: Current Status, Journal of Investigative Dermatology, vol.96, issue.3, pp.2-4, 1991.
DOI : 10.1111/1523-1747.ep12468882

P. Valent and . Biology, classification and treatment of human mastocytosis, Wien Klin Wochenschr, vol.108, pp.385-397, 1996.

P. Valent, . Hh-p, L. Escribano, B. Longley, C. Li et al., World Health Organization (WHO) Classification of tumours, 2001.

P. Valent, C. Akin, and W. Sperr, Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria, Leukemia Research, vol.27, issue.7, pp.635-641, 2003.
DOI : 10.1016/S0145-2126(02)00168-6
URL : https://hal.archives-ouvertes.fr/hal-00282564

J. Gotlib, C. Berube, and J. Growney, Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation, Blood, vol.106, issue.8, pp.2865-2870, 2005.
DOI : 10.1182/blood-2005-04-1568

F. Noack, K. Sotlar, M. Notter, E. Thiel, P. Valent et al., Aleukemic Mast Cell Leukemia with Abnormal Immunophenotype and C-kit Mutation D816V, Leukemia & Lymphoma, vol.12, issue.1, pp.2295-2302, 2004.
DOI : 10.1172/JCI116761

C. Valentini, M. Rondoni, and E. Pogliani, Mast cell leukemia: a report of ten cases, Annals of Hematology, vol.34, issue.6, pp.505-508, 2008.
DOI : 10.1007/s00277-007-0430-3

F. Bellamy, T. Bader, A. Moussy, H. O. Dubreuil, P. Letard et al., Pharmacokinetics of masitinib in cats Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT, Vet Res Commun PLoS One, vol.124, pp.7258-7271, 2009.

S. Letard, Y. Yang, and K. Hanssens, Gain-of-Function Mutations in the Extracellular Domain of KIT Are Common in Canine Mast Cell Tumors, Molecular Cancer Research, vol.6, issue.7, pp.1137-1145, 2008.
DOI : 10.1158/1541-7786.MCR-08-0067

M. Humbert, N. Casteran, and S. Letard, Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model, PLoS ONE, vol.5, issue.3, pp.9430-9446
DOI : 10.1371/journal.pone.0009430.s003
URL : https://hal.archives-ouvertes.fr/hal-00473110

L. Cesne, A. Blay, J. Bui, and B. , Phase II study of oral masitinib mesilate in imatinib-naive patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST) Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers, Eur J Cancer. Eur J Cancer, vol.1745, pp.2333-2341, 2009.

J. Tebib, M. X. Bourgeois, and P. , Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations, Arthritis Res Ther. J Invest Dermatol, vol.11130, pp.804-815, 2009.

O. Hermine, O. Lortholary, and P. Leventhal, Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis, PLoS ONE, vol.14, issue.5, p.2266, 2008.
DOI : 10.1371/journal.pone.0002266.s002
URL : https://hal.archives-ouvertes.fr/hal-00284181